The escalating controversy around the Indian contract research organization (CRO), GVK Biosciences, appears to have more layers to it than just flawed electrocardiogram (ECG) data flagged up by the French regulator.
Allegations of vendetta and possibly bruised egos, inadequate "scientific discussion" around the issue alongside some evidence that potentially backs the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?